Role of bile acids in metabolic control

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457 · see citing works

Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories: A Systematic Review and Meta-analysis

Flegal, K. M., Kit, B. K., Orpana, H., & Graubard, B. I. (2013) · JAMA · doi:10.1001/jama.2012.113905 · Cited by 3,998 · see citing works

Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice

Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788 · see citing works

Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism

Wahlstrom, A. M., Sayin, S. I., Marschall, H., & Bäckhed, F. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.005 · Cited by 2,903 · see citing works

Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist

Sayin, S. I., Wahlström, A., Felin, J., Jäntti, S., Marschall, H.-U., Bamberg, K., Angelin, B., Hyötyläinen, T., Orešič, M., & Bäckhed, F. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.01.003 · Cited by 2,331 · see citing works

Nonalcoholic Fatty Liver Disease

Rinella, M. E. (2015) · JAMA · doi:10.1001/jama.2015.5370 · Cited by 2,320 · see citing works

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): A multicentre, randomised, placebo-controlled trial

Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237 · see citing works

Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation

Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T., et al. (2006) · Nature · doi:10.1038/nature04330 · Cited by 2,220 · see citing works

TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis

Thomas, C., Gioiello, A., Noriega, L., Strehle, A., Oury, J., Rizzo, G., Macchiarulo, A., Yamamoto, H., Mataki, C., Pruzanski, M., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.08.001 · Cited by 1,885 · see citing works

The global NAFLD epidemic

Loomba, R. S., & Sanyal, A. J. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.171 · Cited by 1,732 · see citing works

Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug

Wu, H., Esteve, E., Tremaroli, V., Khan, M. T., Caesar, R., Mannerås-Holm, L., Ståhlman, M., Olsson, L. M., Serino, M., Planas-Fèlix, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4345 · Cited by 1,632 · see citing works

Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease

Loomba, R., Seguritan, V., Li, W., Long, T., Klitgord, N., Bhatt, A., Dulai, P. S., Caussy, C., Bettencourt, R., Highlander, S. K., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.001 · Cited by 1,123 · see citing works

Interactions Between the Intestinal Microbiome and Liver Diseases

Schnabl, B., & Brenner, D. A. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.020 · Cited by 971 · see citing works

Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease

Chávez-Talavera, O., Tailleux, A., Lefebvre, P., & Staels, B. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.055 · Cited by 970 · see citing works

Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling

Caesar, R., Tremaroli, V., Kovatcheva-Datchary, P., Cani, P. D., & Bäckhed, F. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.026 · Cited by 960 · see citing works

FXR is a molecular target for the effects of vertical sleeve gastrectomy

Ryan, K. K., Tremaroli, V., Clemmensen, C., Kovatcheva-Datchary, P., Myronovych, A., Karns, R., Wilson-Pérez, H. E., Sandoval, D. A., Kohli, R., Bäckhed, F., et al. (2014) · Nature · doi:10.1038/nature13135 · Cited by 931 · see citing works

Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease

Mudaliar, S., Henry, R. R., Sanyal, A. J., Morrow, L., Marschall, H., Kipnes, M., Adorini, L., Sciacca, C. I., Clopton, P., Castelloe, E., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.05.042 · Cited by 931 · see citing works

Roux-en-Y Gastric Bypass and Vertical Banded Gastroplasty Induce Long-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation

Tremaroli, V., Karlsson, F., Werling, M., Ståhlman, M., Kovatcheva-Datchary, P., Olbers, T., Fändriks, L., le Roux, C. W., Nielsen, J., & Bäckhed, F. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.009 · Cited by 757 · see citing works

Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance

Fang, S., Suh, J. M., Reilly, S. M., Yu, E., Osborn, O., Lackey, D., Yoshihara, E., Perino, A., Jacinto, S., Lukasheva, Y., et al. (2015) · Nature Medicine · doi:10.1038/nm.3760 · Cited by 738 · see citing works

Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD

Jiao, N., Baker, S. S., Chapa-Rodriguez, A., Liu, W., Nugent, C. A., Tsompana, M., Mastrandrea, L., Buck, M. J., Baker, R. D., Genco, R. J., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-314307 · Cited by 737 · see citing works

Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity

Li, F., Jiang, C., Krausz, K. W., Li, Y., Albert, I., Hao, H., Fabre, K. M., Mitchell, J. B., Patterson, A. D., & Gonzalez, F. J. (2013) · Nature Communications · doi:10.1038/ncomms3384 · Cited by 705 · see citing works

Bile acid receptors as targets for drug development

Schaap, F. G., Trauner, M., & Jansen, P. L. M. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.151 · Cited by 696 · see citing works

Increased Hepatic Synthesis and Dysregulation of Cholesterol Metabolism Is Associated with the Severity of Nonalcoholic Fatty Liver Disease

Min, H., Kapoor, A., Fuchs, M. A., Mirshahi, F., Zhou, H., Maher, J. W., Kellum, J. M., Warnick, R., Contos, M. J., & Sanyal, A. J. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.004 · Cited by 653 · see citing works

Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives

Arab, J. P., Karpen, S. J., Dawson, P. A., Arrese, M., & Trauner, M. (2017) · Hepatology · doi:10.1002/hep.28709 · Cited by 634 · see citing works

Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction

Jiang, C., Xie, C., Lv, Y., Li, J., Krausz, K. W., Shi, J., Brocker, C. N., Desai, D., Amin, S. G., Bisson, W. H., et al. (2015) · Nature Communications · doi:10.1038/ncomms10166 · Cited by 559 · see citing works

Microbiota-induced obesity requires farnesoid X receptor

Parséus, A., Sommer, N., Sommer, F., Caesar, R., Molinaro, A., Ståhlman, M., Greiner, T. U., Perkins, R., & Bäckhed, F. (2016) · Gut · doi:10.1136/gutjnl-2015-310283 · Cited by 481 · see citing works

The Bile Acid Chenodeoxycholic Acid Increases Human Brown Adipose Tissue Activity

Broeders, E. P. M., Nascimento, E. B. M., Havekes, B., Brans, B. T., Roumans, K. H. M., Tailleux, A., Schaart, G., Kouach, M., Charton, J., Deprez, B. P., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.002 · Cited by 452 · see citing works

The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids

Puri, P., Daita, K., Joyce, A., Mirshahi, F., Santhekadur, P. K., Cazanave, S., Luketic, V. A., Siddiqui, M. S., Boyett, S., Min, H., et al. (2018) · Hepatology · doi:10.1002/hep.29359 · Cited by 426 · see citing works

Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells

Trabelsi, M.-S., Daoudi, M., Prawitt, J., Ducastel, S., Touche, V., Sayin, S. I., Perino, A., Brighton, C. A., Sebti, Y., Kluza, J., et al. (2015) · Nature Communications · doi:10.1038/ncomms8629 · Cited by 404 · see citing works

Tauroursodeoxycholic Acid May Improve Liver and Muscle but Not Adipose Tissue Insulin Sensitivity in Obese Men and Women

Kars, M., Yang, L., Gregor, M. F., Mohammed, B. S., Pietka, T., Finck, B. N., Patterson, B. W., Horton, J. D., Mittendorfer, B., Hotamışlıgil, G. S., et al. (2010) · Diabetes · doi:10.2337/db10-0308 · Cited by 400 · see citing works

The Farnesoid X-receptor Is an Essential Regulator of Cholesterol Homeostasis

Lambert, G. C., Amar, M. J., Guo, G. L., Brewer, H. B., Gonzalez, F. J., & Sinal, C. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209525200 · Cited by 393 · see citing works

Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease

Mouzaki, M., Wang, A. Y., Bandsma, R., Comelli, E. M., Arendt, B. M., Zhang, L., Fung, S., Fischer, S. E., McGilvray, I. G., & Allard, J. P. (2016) · PLOS ONE · doi:10.1371/journal.pone.0151829 · Cited by 385 · see citing works

Farnesoid X Receptor Deficiency Improves Glucose Homeostasis in Mouse Models of Obesity

Prawitt, J., Abdelkarim, M., Stroeve, J. H. M., Popescu, I. R., Duez, H., Velagapudi, V., Dumont, J., Bouchaert, E., van Dijk, T. H., Lucas, A., et al. (2011) · Diabetes · doi:10.2337/db11-0030 · Cited by 327 · see citing works

Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity

Mueller, M., Thorell, A., Claudel, T., Jha, P., Köfeler, H. C., Lackner, C., Hoesel, B., Fauler, G., Stojaković, T., Einarsson, C., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.034 · Cited by 314 · see citing works

Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota

Pallejá, A., Kashani, A., Allin, K. H., Nielsen, T., Zhang, C., Li, Y., Brach, T., Liang, S., Feng, Q., Jørgensen, N. B., et al. (2016) · Genome Medicine · doi:10.1186/s13073-016-0312-1 · Cited by 312 · see citing works

Novel Potent and Selective Bile Acid Derivatives as TGR5 Agonists: Biological Screening, Structure−Activity Relationships, and Molecular Modeling Studies

Sato, H., Macchiarulo, A., Thomas, C., Gioiello, A., Une, M., Hofmann, A. F., Saladin, R., Schoonjans, K., Pellicciari, R., & Auwerx, J. H. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7015864 · Cited by 302 · see citing works

Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice

Maruyama, T., Tanaka, K., Suzuki, J., Miyoshi, H., Harada, N., Nakamura, T., Miyamoto, Y., Kanatani, A., & Tamai, Y. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06546 · Cited by 285 · see citing works

All Bariatric Surgeries Are Not Created Equal: Insights from Mechanistic Comparisons

Stefater, M. A., Wilson, H., Chambers, A. P., Sandoval, D. A., & Seeley, R. J. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1044 · Cited by 281 · see citing works

Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation

Vassileva, G., Golovko, A., Markowitz, L., Abbondanzo, S. J., Zeng, M., Yang, S., Hoos, L. M., Tetzloff, G. G., Levitan, D. J., Murgolo, N., et al. (2006) · Biochemical Journal · doi:10.1042/bj20060537 · Cited by 277 · see citing works

Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism

Pathak, P., Liu, H., Boehme, S., Xie, C., Krausz, K. W., Gonzalez, F. J., & Chiang, J. Y. L. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.784322 · Cited by 257 · see citing works

The Importance of Caloric Restriction in the Early Improvements in Insulin Sensitivity After Roux-en-Y Gastric Bypass Surgery

Isbell, J. M., Tamboli, R. A., Hansen, E. N., Saliba, J., Dunn, J. P., Phillips, S. E., Marks–Shulman, P. A., & Abumrad, N. N. (2010) · Diabetes Care · doi:10.2337/dc09-2107 · Cited by 248 · see citing works

Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis

Bechmann, L. P., Kocabayoglu, P., Sowa, J., Sydor, S., Best, J., Schlattjan, M., Beilfuss, A., Schmitt, J., Hannivoort, R. A., Kılıçarslan, A., et al. (2013) · Hepatology · doi:10.1002/hep.26225 · Cited by 235 · see citing works

Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease

Yang, Z., Shen, W., & Sun, H. (2010) · Hepatology International · doi:10.1007/s12072-010-9202-6 · Cited by 225 · see citing works

Bile acid levels are increased in the liver of patients with steatohepatitis

Aranha, M. M., Cortez‐Pinto, H., Costa, A., da Silva, I. M., Camilo, M., de Moura, M. C., & Rodrigues, C. M. P. (2008) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3282f4710a · Cited by 211 · see citing works

Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet–fed mice

Rao, A., Kosters, A., Mells, J. E., Zhang, W., Setchell, K. D. R., Amanso, A. M., Wynn, G. M., Xu, T., Keller, B. T., Yin, H., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf4823 · Cited by 211 · see citing works

TGR5 contributes to glucoregulatory improvements after vertical sleeve gastrectomy in mice

McGavigan, A. K., Garibay, D., Henseler, Z. M., Chen, J. C., Bettaieb, A., Haj, F. G., Ley, R. E., Chouinard, M. L., & Cummings, B. P. (2015) · Gut · doi:10.1136/gutjnl-2015-309871 · Cited by 210 · see citing works

Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease

Lake, A. D., Novák, P., Shipkova, P. A., Aranı́bar, N., Robertson, D. G., Reily, M. D., Lu, Z. J., Lehman‐McKeeman, L. D., & Cherrington, N. J. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.01.022 · Cited by 189 · see citing works

Vertical sleeve gastrectomy activates GPBAR‐1/TGR5 to sustain weight loss, improve fatty liver, and remit insulin resistance in mice

Ding, L., Sousa, K. M., Jin, L., Dong, B., Kim, B., Ramírez, R., Xiao, Z., Gu, Y., Yang, Q., Wang, J., et al. (2016) · Hepatology · doi:10.1002/hep.28689 · Cited by 180 · see citing works

Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery

Flynn, C. R., Albaugh, V. L., Cai, S. B., Cheung‐Flynn, J., Williams, P. E., Brucker, R. M., Bordenstein, S. R., Guo, Y. P., Wasserman, D. H., & Abumrad, N. N. (2015) · Nature Communications · doi:10.1038/ncomms8715 · Cited by 176 · see citing works

Non-alcoholic steatohepatitis: a microbiota-driven disease

Moschen, A. R., Kaser, S., & Tilg, H. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.05.009 · Cited by 176 · see citing works

Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study

Beysen, C., Murphy, E. J., Deines, K., Chan, M., Tsang, E., Glass, A., Turner, S., Protasio, J., Riiff, T. J., & Hellerstein, M. K. (2011) · Diabetologia · doi:10.1007/s00125-011-2382-3 · Cited by 163 · see citing works

Impaired Generation of 12-Hydroxylated Bile Acids Links Hepatic Insulin Signaling with Dyslipidemia

Haeusler, R. A., Pratt–Hyatt, M., Welch, C. L., Klaassen, C. D., & Accili, D. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.11.010 · Cited by 154 · see citing works

Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis

Feaver, R. E., Cole, B. K., Lawson, M. J., Hoang, S. A., Marukian, S., Blackman, B. R., Figler, R. A., Sanyal, A. J., Wamhoff, B. R., & Dash, A. (2016) · JCI Insight · doi:10.1172/jci.insight.90954 · Cited by 153 · see citing works

Bile acids and bariatric surgery

Albaugh, V. L., Banan, B., Ajouz, H., Abumrad, N. N., & Flynn, C. R. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.04.001 · Cited by 148 · see citing works

Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis

Kumar, D. P., Asgharpour, A., Mirshahi, F., Park, S. H., Liu, S., Imai, Y., Nadler, J. L., Grider, J. R., Murthy, K. S., & Sanyal, A. J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.699504 · Cited by 144 · see citing works

Intestinal Farnesoid X Receptor Controls Transintestinal Cholesterol Excretion in Mice

de Boer, J. F., Schonewille, M., Boesjes, M., Wolters, H., Bloks, V. W., Bos, T., van Dijk, T. H., Jurdzinski, A., Boverhof, R., Wolters, J. C., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.12.037 · Cited by 142 · see citing works

Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal

Schmitt, J., Kong, B., Stieger, B., Tschopp, O., Schultze, S. M., Rau, M., Weber, A., Müllhaupt, B., Guo, G. L., & Geier, A. (2014) · Liver International · doi:10.1111/liv.12456 · Cited by 141 · see citing works

Early Increases in Bile Acids Post Roux-en-Y Gastric Bypass Are Driven by Insulin-Sensitizing, Secondary Bile Acids

Albaugh, V. L., Flynn, C. R., Cai, S. B., Xiao, Y., Tamboli, R. A., & Abumrad, N. N. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2467 · Cited by 126 · see citing works

Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid Metabolism

Zhang, L., Xie, C., Nichols, R. G., Chan, S. H. J., Jiang, C., Hao, R., Smith, P. B. W., Cai, J., Simons, M., Hatzakis, E., et al. (2016) · mSystems · doi:10.1128/msystems.00070-16 · Cited by 126 · see citing works

Loss of Cyp8b1 Improves Glucose Homeostasis by Increasing GLP-1

Kaur, A., Patankar, J. V., de Haan, W., Ruddle, P., Wijesekara, N., Groen, A. K., Verchere, C. B., Singaraja, R. R., & Hayden, M. R. (2014) · Diabetes · doi:10.2337/db14-0716 · Cited by 124 · see citing works

Modulation of the gut microbiota impacts nonalcoholic fatty liver disease: a potential role for bile acids

Janssen, A. W. F., Houben, T., Katiraei, S., Dijk, W., Boutens, L., van der Bolt, N., Wang, Z., Brown, J. M., Hazen, S. L., Mandard, S., et al. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m075713 · Cited by 121 · see citing works

The Physiology and Molecular Underpinnings of the Effects of Bariatric Surgery on Obesity and Diabetes

Evers, S. S., Sandoval, D. A., & Seeley, R. J. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034423 · Cited by 118 · see citing works

Identification of Novel Pathways That Control Farnesoid X Receptor-mediated Hypocholesterolemia

Zhang, Y., Yin, L., Anderson, J., Ma, H., Gonzalez, F. J., Willson, T. M., & Edwards, P. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.083899 · Cited by 112 · see citing works

Hepatic FXR/SHP axis modulates systemic glucose and fatty acid homeostasis in aged mice

Kim, K. H., Choi, S., Zhou, Y., Kim, E. Y., Lee, J. M., Saha, P. K., Anakk, S., & Moore, D. D. (2017) · Hepatology · doi:10.1002/hep.29199 · Cited by 107 · see citing works

Heritability: The family roots of obesity

Willyard, C. (2014) · Nature · doi:10.1038/508s58a · Cited by 97 · see citing works

The ileal bile acid transporter inhibitor A4250 decreases serum bile acids by interrupting the enterohepatic circulation

Graffner, H., Gillberg, P., Rikner, L., & Marschall, H. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13457 · Cited by 94 · see citing works

Induction of farnesoid X receptor signaling in germ-free mice colonized with a human microbiota

Wahlstrom, A. M., Kovatcheva‐Datchary, P., Ståhlman, M., Khan, M.-T., Bäckhed, F., & Marschall, H. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m072819 · Cited by 87 · see citing works

Vertical Sleeve Gastrectomy Improves Glucose and Lipid Metabolism and Delays Diabetes Onset in UCD-T2DM Rats

Cummings, B. P., Bettaieb, A., Graham, J. L., Stanhope, K. L., Kowala, M. C., Haj, F. G., Chouinard, M. L., & Havel, P. J. (2012) · Endocrinology · doi:10.1210/en.2012-1131 · Cited by 85 · see citing works

Bile acid sequestrants for glycemic control in patients with type 2 diabetes: A systematic review with meta-analysis of randomized controlled trials

Hansen, M., Sonne, D. P., Mikkelsen, S. U., Gluud, L. L., Vilsbøll, T., & Knop, F. K. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.01.011 · Cited by 85 · see citing works

Effects of obeticholic acid on lipoprotein metabolism in healthy volunteers

Pencek, R., Marmon, T., Roth, J. D., Liberman, A., Hooshmand-Rad, R., & Young, M. A. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12681 · Cited by 67 · see citing works

Serum Bile Acid Levels in Children With Nonalcoholic Fatty Liver Disease

Jahnel, J., Zöhrer, E., Alisi, A., Ferrari, F., Ceccarelli, S., Vito, R. D., Scharnagl, H., Stojaković, T., Fauler, G., Trauner, M. A., et al. (2015) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000774 · Cited by 60 · see citing works

Serum bile acids and GLP-1 decrease following telemetric induced weight loss: results of a randomized controlled trial

Biemann, R., Penner, M., Borucki, K., Westphal, S., Luley, C. H., Rönicke, R., Biemann, K., Weikert, C., Lux, A., Goncharenko, N., et al. (2016) · Scientific Reports · doi:10.1038/srep30173 · Cited by 36 · see citing works

The Presence and Severity of Nonalcoholic Steatohepatitis Is Associated with Specific Changes in Circulating Bile Acids

Gottlieb, A., Bechmann, L. P., & Canbay, A. E. (2018) · Annals of Hepatology · doi:10.5604/01.3001.0011.7378 · Cited by 32 · see citing works

Effects of acute dietary weight loss on postprandial plasma bile acid responses in obese insulin resistant subjects

van Nierop, F. S., Kulik, W., Endert, E., Schaap, F. G., Damink, S. W. M. O., Romijn, J. A., & Soeters, M. R. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.10.006 · Cited by 18 · see citing works

Ursodeoxycholic Acid for Treatment of Fatty Liver Disease and Dyslipidemia in Morbidly Obese Patients

Marschall, H., Wagner, M., Zollner, G., Fickert, P., Lackner, C., Thorell, A., & Trauner, M. A. (2011) · Digestive Diseases · doi:10.1159/000324146 · Cited by 11 · see citing works

Bariatric Surgery: The Rise and Fall of Bile Acids

Khan, F. H., & Kohli, R. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2015.12.027 · Cited by 6 · see citing works

Bile acids and the gut microbiota: metabolic interactions and impacts on disease

Collins, S. L., Stine, J. G., Bisanz, J. E., Okafor, C. D., & Patterson, A. D. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00805-x · Cited by 1,214 · see citing works

Gut microbial β-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens

Ervin, S. M., Li, H., Lim, L., Roberts, L. R., Liang, X., Mani, S., & Redinbo, M. R. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010950 · Cited by 397 · see citing works

Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis

Rao, Y., Kuang, Z., Li, C., Guo, S., Xu, Y., Zhao, D., Hu, Y., Song, B., Jiang, Z., Ge, Z., et al. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1927633 · Cited by 356 · see citing works

Metabolic Messengers: bile acids

Perino, A., & Schoonjans, K. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00559-z · Cited by 223 · see citing works

The biosynthesis, signaling, and neurological functions of bile acids

Kiriyama, Y., & Nochi, H. (2019) · Biomolecules · doi:10.3390/biom9060232 · Cited by 204 · see citing works

Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis

Chen, W., Wei, Y., Xiong, A., Li, Y., Guan, H., Wang, Q., Miao, Q., Bian, Z., Xiao, X., Lian, M., et al. (2020) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-019-08731-2 · Cited by 166 · see citing works

Role of bile acids in inflammatory liver diseases

Evangelakos, I., Heeren, J., Verkade, E., & Kuipers, F. (2021) · Seminars in Immunopathology · doi:10.1007/s00281-021-00869-6 · Cited by 121 · see citing works

Bile acids as key modulators of the brain-Gut-Microbiota axis in alzheimer’s disease

Mulak, A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210608 · Cited by 114 · see citing works

Quantification of bile acids: a mass spectrometry platform for studying gut microbe connection to metabolic diseases

Choucair, I., Nemet, I., Li, L., Cole, M. A., Skye, S. M., Kirsop, J. D., Fischbach, M. A., Gogonea, V., Brown, J. M., Tang, W. H. W., et al. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra119000311 · Cited by 77 · see citing works

A Comprehensive Genome Survey Provides Novel Insights into Bile Salt Hydrolase (BSH) in Lactobacillaceae

Liang, L., Yi, Y., Lv, Y., Qian, J., Lei, X., & Zhang, G. (2018) · Molecules · doi:10.3390/molecules23051157 · Cited by 38 · see citing works

<i>Lactiplantibacillus plantarum</i> strains KABP011, KABP012, and KABP013 modulate bile acids and cholesterol metabolism in humans

Padro, T., Santisteban, V., Huedo, P., Puntes, M., Aguiló, M., Espadaler-Mazo, J., & Badimon, L. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae061 · Cited by 32 · see citing works

Toward Precision Weight-Loss Dietary Interventions: Findings from the POUNDS Lost Trial

Qi, L., Heianza, Y., Li, X., Sacks, F. M., & Bray, G. A. (2023) · Nutrients · doi:10.3390/nu15163665 · Cited by 17 · see citing works

Involvement of corepressor complex subunit GPS2 in transcriptional pathways governing human bile acid biosynthesis

Sanyal, S., Båvner, A., Haroniti, A., Nilsson, L.-M., Lundåsen, T., Rehnmark, S., Witt, M. R., Einarsson, C., Talianidis, I., Gustafsson, J.-Α., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706736104 · Cited by 95 · see citing works

3ML09 Epidemiology of vascular disease

Kuller, L. H. (2003) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(03)90832-4

FXR signaling in the enterohepatic system

Matsubara, T., Li, F., & Gonzalez, F. J. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.05.004 · Cited by 383 · see citing works

Role of FXR in Regulating Bile Acid Homeostasis and Relevance for Human Diseases

Rizzo, G., Renga, B., Mencarelli, A., Pellicciari, R., & Fiorucci, S. (2005) · Current Drug Targets - Immune Endocrine & Metabolic Disorders · doi:10.2174/1568008054863781 · Cited by 112 · see citing works

A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis

Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940 · see citing works